Related Experiment Video
Updated: Jul 19, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
04:12
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Carcinogenesis and the hypothesis of phylogenetic reversion
Peter H Bartels1, James Ranger-Moore, David Alberts
1Optical Sciences Center and Arizona Cancer Center, Division of Epidemiology and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724, USA. jrangerm@azcc.arizona.edu
Analytical and Quantitative Cytology and Histology
|October 28, 2006
Summary
Chemoprevention strategies must address early molecular changes in cancer development. Karyometry, a biomarker of chromatin patterns, can detect these initial transformation events and monitor chemopreventive agent efficacy.
Area of Science:
- Oncology
- Epigenetics
- Complexity Science
Background:
- Malignant transformation involves poorly understood molecular events, hindering chemoprevention.
- The roles of mutagenic versus epigenetic mechanisms in carcinogenesis are not fully established.
- Traditional models lack a comprehensive understanding of cellular responses during cancer development.
Purpose of the Study:
- To explore cancer development through the lens of complexity science, focusing on system responses.
- To propose a novel approach for identifying and monitoring early molecular events in carcinogenesis.
- To evaluate karyometry as a sensitive biomarker for detecting early cancer progression.
Main Methods:
- Applying complexity science principles to model cellular responses and feedback mechanisms in carcinogenesis.
- Investigating epigenetic redifferentiation and phylogenetic reversion as key processes in cancer.
- Utilizing karyometry to analyze nuclear chromatin patterns as an integrating biomarker.
Main Results:
- Carcinogenesis is conceptualized as epigenetic redifferentiation, leading to uncontrolled cell growth.
- Silencing of growth-restraining genes via heterochromatin formation and hypermethylation is implicated.
- Karyometry demonstrates high sensitivity in detecting early cellular transformation events.
Conclusions:
- Karyometry serves as a sensitive, integrating biomarker for early detection of cancer progression.
- This approach can monitor the effectiveness of chemopreventive agents targeting initial molecular alterations.
- Understanding carcinogenesis as a system response offers new avenues for chemoprevention research.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...